Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101565685A reveals a novel recombinant E. coli strain for producing chiral acetoin and 2,3-butanediol with high ee values, offering significant cost reduction in chiral chemical manufacturing.
Patent CN111606838B reveals a green hydrothermal method for bis-indolylmethane synthesis, eliminating toxic catalysts and reducing waste for reliable pharma intermediate supply.
Patent CN103524408A details a high-yield, water-based synthesis of 7-Chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103524408A details a high-yield aqueous synthesis of 7-chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN103524408A details a high-yield aqueous synthesis of 7-Chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Patent CN105131015B reveals a green solid acid method for 7-AVCA. This offers cost reduction and supply chain reliability for antibiotic manufacturers.
Novel synthesis of 1,3-disubstituted pyrazoles as AR antagonists. Efficient route for pharma intermediates with scalable steps and high purity.
Novel synthesis route for monocyclic beta-lactam compounds offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN103025743B reveals a scalable method for cyclic carbodiimide synthesis. Achieve superior hydrolysis stability and cost reduction in polymer additive manufacturing.
Patent CN116875576B reveals mutant LeuDH for L-phenylglycine. Offers high conversion, ee >99%, and scalable biocatalysis for pharmaceutical supply chains.
Patent CN115611866B details a safer cyclohexene reduction route for tandospirone citrate ensuring high purity and simplified supply chain for global pharmaceutical intermediates manufacturing.
Patent CN112876355B reveals a novel Co-N-C catalyzed route for converting secondary alcohols to esters via C-C bond cleavage, offering superior yields and greener processing for pharmaceutical supply chains.
Patent CN1109876A details a novel hydrolysis process for acid chlorides using FeCl3 and chlorocarbon solvents, offering high purity and scalable routes for pharmaceutical intermediates.
Patent CN104131048A reveals high-yield biological synthesis for chiral intermediates. Achieve superior purity and cost efficiency in pharmaceutical manufacturing supply chains.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN101157650B details an ionic liquid-catalyzed route using dimethyl carbonate, offering high purity and safety for pharmaceutical intermediates.
Patent CN103804413A reveals a novel biphenyl triphosphine ligand synthesis enhancing hydroformylation selectivity and offering significant cost reduction in fine chemical manufacturing.
Patent CN114315660B enables transition-metal-free synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally. Offers significant cost reduction and scalability.